Patient outcomes and clinical characteristics of ATTR-CM patients treated with tafamidis: A single center experience in Turkey - Study ATTREAL

01/07/2025
28/01/2026
EU PAS number:
EUPAS1000000561
Study
Ongoing
Documents
Study protocol
Initial protocol
English (12.34 MB - PDF) View document
Updated protocol
English (5.89 MB - PDF) View document
Study results
Study report
Other information